肌腱蛋白C(TNC)多克隆抗體
Polyclonal Antibody to Tenascin C (TNC)
TN-C; HXB; TN; GMEM; JI; Myotendinous antigen; Neuronectin; GP 150-225; Cytotactin; Hexabrachion; Glioma-associated-extracellular matrix antigen
- 編號(hào)PAB975Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來(lái)源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 RPB975Hu02-肌腱蛋白C(TNC)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.5mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 603 ¥ 1407 ¥ 2010 ¥ 5025 ¥ 20100
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對(duì)TNC的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別TNC。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB975Hu02 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB975Hu01 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB975Hu01 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
PAB975Hu02 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
LAB975Hu71 | 肌腱蛋白C(TNC)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB975Hu22 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu21 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu23 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu24 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
SEB975Hu | 肌腱蛋白C(TNC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB975Hu | 肌腱蛋白C(TNC)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Medical Principles and Practice | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty [Pubmed: 22889719] |
Tumor Biology | Clinical significance of serum tenascin-c levels in epithelial ovarian cancer [Springer: Source] |
Tumor Biology | Clinical significance of serum tenascin-C levels in breast cancer [Springer: Source] |
BioFactors | Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. [Pubmed:24823872] |
Connective Tissue Research | Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes [Pubmed:25333747] |
K | Role of Tenascin-C in the differential diagnosis of small round blue cell tumors [Index.Php: Sdutfd] |
Life Sci | A new predictor of mortality in hemodialysis patients; Tenascin-C [PubMed: 26390818] |
Heart Research | Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention [Heartresearchopenjournal: Hroj5] |
Ara?t?rmalar / Researches | Pankreas Adenokarsinomunda Serum Tenascin-C Düzeyi Potansiyel Bir Biyobelirte? Midir? [Cpdf:5C21620161255] |
Archives of Dermatological Research | Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease [Pubmed:29605863] |
Methods?in?Cell?Biology | How to detect and purify tenascin-C [Pubmed:29310788] |
Scientific Reports | Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion [Pubmed: 31358880] |